{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:51:21Z","timestamp":1791165081651,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100032028","name":"Astrogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-59907-8","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:06:31Z","timestamp":1783184791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["miRNA-mediated therapeutic effects of AST-001 through modulation of key marker genes in autism spectrum disorder"],"prefix":"10.1038","volume":"16","author":[{"given":"Du Hyeong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Gyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Ryung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon-su","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Young","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga-ram","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Kyeong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungwan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heui-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"issue":"19","key":"59907_CR1","doi-asserted-by":"publisher","first-page":"R786","DOI":"10.1016\/j.cub.2005.09.033","volume":"15","author":"U Frith","year":"2005","unstructured":"Frith, U. & Happ\u00e9, F. Autism spectrum disorder. Curr. Biol. 15(19), R786\u2013R790 (2005).","journal-title":"Curr. Biol."},{"issue":"2","key":"59907_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/jama.2022.23661","volume":"329","author":"T Hirota","year":"2023","unstructured":"Hirota, T. & King, B. H. Autism spectrum disorder: a review. Jama 329(2), 157\u2013168 (2023).","journal-title":"Jama"},{"issue":"3","key":"59907_CR3","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1086\/724794","volume":"10","author":"NM Daysal","year":"2024","unstructured":"Daysal, N. M., Elder, T. E., Hellerstein, J. K., Imberman, S. A. & Orsini, C. Parental skills, assortative mating, and the incidence of autism spectrum disorder. Am. J. Health Econ. 10(3), 322\u2013356 (2024).","journal-title":"Am. J. Health Econ."},{"key":"59907_CR4","doi-asserted-by":"crossref","unstructured":"Conant, L. L. & Miller, L. E. Intellectual developmental disorder, autism spectrum disorder, attention-deficit\/hyperactivity disorder, and specific learning disorders across the lifespan. in Clinical neuropsychology: A pocket handbook for assessment (ed. 4th.) 587\u2013617 (American Psychological Association, 2024).","DOI":"10.1037\/0000383-022"},{"issue":"2","key":"59907_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/epirev\/mxf010","volume":"24","author":"CJ Newschaffer","year":"2002","unstructured":"Newschaffer, C. J., Fallin, D. & Lee, N. L. Heritable and nonheritable risk factors for autism spectrum disorders. Epidemiol. Rev. 24(2), 137\u2013153 (2002).","journal-title":"Epidemiol. Rev."},{"issue":"8","key":"59907_CR6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/ng.3039","volume":"46","author":"T Gaugler","year":"2014","unstructured":"Gaugler, T. et al. Most genetic risk for autism resides with common variation. Nat. Genet. 46(8), 881\u2013885 (2014).","journal-title":"Nat. Genet."},{"issue":"1","key":"59907_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13229-017-0121-4","volume":"8","author":"A Modabbernia","year":"2017","unstructured":"Modabbernia, A., Verlthorst, E. & Reichenberg, A. Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses. Mol. Autism. 8(1), 13 (2017).","journal-title":"Mol. Autism"},{"key":"59907_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neuint.2014.01.002","volume":"66","author":"M Nguyen","year":"2014","unstructured":"Nguyen, M. et al. Decoding the contribution of dopaminergic genes and pathways to autism spectrum disorder (ASD). Neurochem Int. 66, 15\u201326 (2014).","journal-title":"Neurochem Int."},{"key":"59907_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fncel.2016.00263","volume":"10","author":"YC Lin","year":"2016","unstructured":"Lin, Y. C., Frei, J. A., Kilander, M. B. C., Shen, W. & Blatt, G. J. A subset of autism-associated genes regulate the structural stability of neurons. Front. Cell. Neurosci. 10, 263 (2016).","journal-title":"Front. Cell. Neurosci."},{"key":"59907_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.euroneuro.2021.05.010","volume":"48","author":"JT McCracken","year":"2021","unstructured":"McCracken, J. T. et al. Drug development for autism spectrum disorder (ASD): progress, challenges, and future directions. Eur. Neuropsychopharmacol. 48, 3\u201331 (2021).","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"13","key":"59907_CR11","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.3390\/ijms21134726","volume":"21","author":"A Genovese","year":"2020","unstructured":"Genovese, A. & Butler, M. G. Clinical assessment, genetics, and treatment approaches in autism spectrum disorder (ASD). Int. J. Mol. Sci. 21(13), 4726 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"59907_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/gm144","volume":"2","author":"T Sarachana","year":"2010","unstructured":"Sarachana, T., Zhou, R., Chen, G., Manji, H. K. & Hu, V. W. Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines. Genome Med. 2(4), 23 (2010).","journal-title":"Genome Med."},{"key":"59907_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.freeradbiomed.2019.07.018","volume":"141","author":"KY Kim","year":"2019","unstructured":"Kim, K. Y. et al. l-Serine protects mouse hippocampal neuronal HT22 cells against oxidative stress-mediated mitochondrial damage and apoptotic cell death. Free Radic Biol. Med. 141, 447\u2013460 (2019).","journal-title":"Free Radic Biol. Med."},{"key":"59907_CR14","doi-asserted-by":"publisher","first-page":"891227","DOI":"10.3389\/fphar.2022.891227","volume":"13","author":"S Lee","year":"2022","unstructured":"Lee, S., Hwang, S., Nam, H., Cho, J. & Chung, J. Population pharmacokinetic model of AST-001, L-isomer of serine, combining endogenous production and exogenous administration in healthy subjects. Front. Pharmacol. 13, 891227 (2022).","journal-title":"Front. Pharmacol."},{"issue":"12","key":"59907_CR15","first-page":"3283","volume":"11","author":"KB Um","year":"2023","unstructured":"Um, K. B., Kwak, S., Cheon, S., Kim, J. & Hwang, S. AST-001 improves social deficits and restores dopamine neuron activity in a mouse model of autism. Biomed 11(12), 3283 (2023).","journal-title":"Biomed"},{"issue":"1","key":"59907_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/pcn.13757","volume":"79","author":"HW Kim","year":"2025","unstructured":"Kim, H. W. et al. AST-001 versus placebo for social communication in children with autism spectrum disorder: A randomized clinical trial. Psychiatry Clin. Neurosci. 79(1), 21\u201328 (2025).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"59907_CR17","doi-asserted-by":"publisher","first-page":"1452526","DOI":"10.3389\/fphar.2024.1452526","volume":"15","author":"S Lee","year":"2024","unstructured":"Lee, S., Hwang, S., Cho, J., Ryu, H. C. & Chung, J. Population pharmacokinetic and pharmacodynamic model guided weight-tiered dose of AST-001 in pediatric patients with autism spectrum disorder. Front. Pharmacol. 15, 1452526 (2024).","journal-title":"Front. Pharmacol."},{"issue":"8","key":"59907_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/bs8080075","volume":"8","author":"TDS Vaccaro","year":"2018","unstructured":"Vaccaro, T. D. S. et al. D. Alterations in the microRNA of the blood of autism spectrum disorder patients: effects on epigenetic regulation and potential biomarkers. Behav. Sci. 8(8), 75 (2018).","journal-title":"Behav. Sci."},{"issue":"1","key":"59907_CR19","first-page":"7526592","volume":"2017","author":"NQV Tran","year":"2017","unstructured":"Tran, N. Q. V. & Miyake, K. Neurodevelopmental disorders and environmental toxicants: epigenetics as an underlying mechanism. Int. J. Genom. 2017(1), 7526592 (2017).","journal-title":"Int. J. Genom"},{"issue":"5","key":"59907_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.4161\/rna.20231","volume":"9","author":"E Matoulkova","year":"2012","unstructured":"Matoulkova, E., Michalova, E., Vojtesek, B. & Hrstka, R. The role of the 3\u2019untranslated region in post-transcriptional regulation of protein expression in mammalian cells. RNA Biol. 9(5), 563\u2013576 (2012).","journal-title":"RNA Biol."},{"key":"59907_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00018-011-0788-1","volume":"69","author":"N Olde Loohuis","year":"2012","unstructured":"Olde Loohuis, N. et al. MicroRNA networks direct neuronal development and plasticity. Cell. Mol. Life Sci. 69, 89\u2013102 (2012).","journal-title":"Cell. Mol. Life Sci."},{"key":"59907_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.brainres.2010.03.107","volume":"1338","author":"R Saba","year":"2010","unstructured":"Saba, R. & Schratt, G. M. MicroRNAs in neuronal development, function and dysfunction. Brain Res. 1338, 3\u201313 (2010).","journal-title":"Brain Res."},{"issue":"9","key":"59907_CR23","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1007\/s00787-023-02138-3","volume":"33","author":"N Garrido-Torres","year":"2023","unstructured":"Garrido-Torres, N. et al. miRNAs as biomarkers of autism spectrum disorder: a systematic review and meta-analysis. Eur. Child. Adolesc. Psychiatry. 33(9), 2957\u20132990 (2023).","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"key":"59907_CR24","doi-asserted-by":"crossref","unstructured":"Shen, L. et al. Advances in biomarker studies in autism spectrum disorders. Rev. Biomark. Stud. Psychiatric Neurodegener. Disord. 207\u2013233 (2019).","DOI":"10.1007\/978-3-030-05542-4_11"},{"key":"59907_CR25","doi-asserted-by":"crossref","unstructured":"Khosroshahi, P. A. & Ghanbari, M. MicroRNA dysregulation in glutamate and dopamine pathways of schizophrenia: From molecular pathways to diagnostic and therapeutic approaches. Prog. Neuropsychopharmacol. Biol. Psychiatry 111081 (2024).","DOI":"10.1016\/j.pnpbp.2024.111081"},{"key":"59907_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.brainres.2015.05.021","volume":"1618","author":"CE Briggs","year":"2015","unstructured":"Briggs, C. E. et al. Midbrain dopamine neurons in Parkinson\u05f3 s disease exhibit a dysregulated miRNA and target-gene network. Brain Res. 1618, 111\u2013121 (2015).","journal-title":"Brain Res."},{"issue":"2","key":"59907_CR27","first-page":"2164","volume":"18","author":"L Yu","year":"2018","unstructured":"Yu, L., Qian, S. & Wei, S. Identification of a noncoding RNA\u2013mediated gene pair\u2013based regulatory module in Alzheimer\u2019s disease. Mol. Med. Rep. 18(2), 2164\u20132170 (2018).","journal-title":"Mol. Med. Rep."},{"key":"59907_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","volume":"299","author":"C Nicolini","year":"2018","unstructured":"Nicolini, C. & Fahnestock, M. The valproic acid-induced rodent model of autism. Exp. Neurol. 299, 217\u2013227 (2018).","journal-title":"Exp. Neurol."},{"key":"59907_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fnbeh.2013.00088","volume":"7","author":"MR Favre","year":"2013","unstructured":"Favre, M. R. et al. Gneral developmental health in the VPA-rat model of autism. Front. Behav. Neurosci. 7, 88 (2013).","journal-title":"Front. Behav. Neurosci."},{"key":"59907_CR30","doi-asserted-by":"publisher","first-page":"110185","DOI":"10.1016\/j.pnpbp.2020.110185","volume":"108","author":"EM Elnahas","year":"2021","unstructured":"Elnahas, E. M. et al. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study. Prog Neuropsychopharmacol. Biol. Psychiatry. 108, 110185 (2021).","journal-title":"Prog Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"59907_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17(1), 10\u201312 (2011).","journal-title":"EMBnet J."},{"issue":"4","key":"59907_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods. 9(4), 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"59907_CR33","doi-asserted-by":"crossref","unstructured":"Liu, X., Han, S., Wang, Z., Gelernter, J. & Yang, B. Variant callers for next-generation sequencing data: a comparison study. PloS ONE 8(9), e75619 (2013).","DOI":"10.1371\/journal.pone.0075619"},{"issue":"1","key":"59907_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/nar\/gkr688","volume":"40","author":"MR Friedl\u00e4nder","year":"2012","unstructured":"Friedl\u00e4nder, M. R., Mackowiak, S. D., Li, N., Chen, W. & Rajewsky, N. miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res. 40(1), 37\u201352 (2012).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"59907_CR35","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara, A., Birgaoanu, M. & Griffiths-Jones, S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 47(D1), D155\u2013D162 (2019).","journal-title":"Nucleic Acids Res."},{"key":"59907_CR36","unstructured":"Lakens, D. & Caldwell, A. Package \u2018TOSTER\u2019. R package (2018)."},{"issue":"6","key":"59907_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.04-1854fje","volume":"19","author":"J Nash","year":"2005","unstructured":"Nash, J., Johnston, T. H., Collingridge, G. L., Garner, C. C. & Brotchie, J. M. Subcellular redistribution of the synapse-associated proteins PSD\u201095 and SAP97 in animal models of Parkinson&s disease and L\u2010DOPA\u2010induced dyskinesia. FASEB J. 19(6), 1\u201325 (2005).","journal-title":"FASEB J."},{"issue":"5","key":"59907_CR38","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/cr.2009.30","volume":"19","author":"P Sun","year":"2009","unstructured":"Sun, P. et al. PSD-95 regulates D1 dopamine receptor resensitization, but not receptor-mediated Gs-protein activation. Cell. Res. 19(5), 612\u2013624 (2009).","journal-title":"Cell. Res."},{"issue":"12","key":"59907_CR39","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1176\/appi.ajp.2010.10040484","volume":"167","author":"M Feyder","year":"2010","unstructured":"Feyder, M. et al. Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams\u2019 syndrome. Am. J. Psychiatry. 167(12), 1508\u20131517 (2010).","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"59907_CR40","doi-asserted-by":"publisher","first-page":"e1001478","DOI":"10.1371\/journal.pbio.1001478","volume":"11","author":"C Cao","year":"2013","unstructured":"Cao, C. et al. Impairment of TrkB-PSD-95 signaling in Angelman syndrome. PLoS Biol. 11(2), e1001478 (2013).","journal-title":"PLoS Biol."},{"issue":"2","key":"59907_CR41","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.braindev.2012.05.013","volume":"35","author":"S Uchino","year":"2013","unstructured":"Uchino, S. & Waga, C. SHANK3 as an autism spectrum disorder-associated gene. Brain Dev. 35(2), 106\u2013110 (2013).","journal-title":"Brain Dev."},{"issue":"6","key":"59907_CR42","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1086\/522590","volume":"81","author":"R Moessner","year":"2007","unstructured":"Moessner, R. et al. Contribution of SHANK3 mutations to autism spectrum disorder. Am. J. Hum. Genet. 81(6), 1289\u20131297 (2007).","journal-title":"Am. J. Hum. Genet."},{"issue":"6286","key":"59907_CR43","doi-asserted-by":"publisher","first-page":"aaf2669","DOI":"10.1126\/science.aaf2669","volume":"352","author":"F Yi","year":"2016","unstructured":"Yi, F. et al. Autism-associated SHANK3 haploinsufficiency causes I h channelopathy in human neurons. Science 352(6286), aaf2669 (2016).","journal-title":"Science"},{"issue":"4","key":"59907_CR44","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1002\/jcp.30067","volume":"236","author":"BL Tang","year":"2021","unstructured":"Tang, B. L. SNAREs and developmental disorders. J. Cell. Physiol. 236(4), 2482\u20132504 (2021).","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"59907_CR45","doi-asserted-by":"publisher","first-page":"7443","DOI":"10.3390\/ijms24087443","volume":"24","author":"A Mesleh","year":"2023","unstructured":"Mesleh, A. et al. Blood Proteomics Analysis Reveals Potential Biomarkers and Convergent Dysregulated Pathways in Autism Spectrum Disorder: A Pilot Study. Int. J. Mol. Sci. 24(8), 7443 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"59907_CR46","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fncel.2015.00071","volume":"6","author":"JC DiFrancesco","year":"2015","unstructured":"DiFrancesco, J. C. & DiFrancesco, D. Dysfunctional HCN ion channels in neurological diseases. Front. Cell. Neurosci. 6, 174 (2015).","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"59907_CR47","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41588-019-0344-8","volume":"51","author":"J Grove","year":"2019","unstructured":"Grove, J. et al. Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51(3), 431\u2013444 (2019).","journal-title":"Nat. Genet."},{"issue":"2","key":"59907_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biopsych.2005.12.008","volume":"60","author":"JJ Gargus","year":"2006","unstructured":"Gargus, J. J. Ion channel functional candidate genes in multigenic neuropsychiatric disease. Biol. Psychiatry. 60(2), 177\u2013185 (2006).","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"59907_CR49","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41401-022-00935-1","volume":"44","author":"YW Nam","year":"2023","unstructured":"Nam, Y. W., Downey, M., Rahman, M. A., Cui, M. & Zhang, M. Channelopathy of small- and intermediate-conductance Ca(2+)-activated K(+) channels. Acta Pharmacol. Sin. 44(2), 259\u2013267 (2023).","journal-title":"Acta Pharmacol. Sin"},{"issue":"2","key":"59907_CR50","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ydbio.2013.04.014","volume":"379","author":"SV Hegarty","year":"2013","unstructured":"Hegarty, S. V., Sullivan, A. M. & O\u2019keeffe, G. W. Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development. Dev. Biol. 379(2), 123\u2013138 (2013).","journal-title":"Dev. Biol."},{"issue":"26","key":"59907_CR51","doi-asserted-by":"publisher","first-page":"14518","DOI":"10.1073\/pnas.94.26.14518","volume":"94","author":"M Schwarz","year":"1997","unstructured":"Schwarz, M., Alvarez-Bolado, G., Urb\u00e1nek, P., Busslinger, M. & Gruss, P. Conserved biological function between Pax-2 and Pax-5 in midbrain and cerebellum development: evidence from targeted mutations. Proc. Natl. Acad. Sci. 94(26), 14518\u201314523 (1997).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"59907_CR52","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.1038\/ncomms6595","volume":"5","author":"BJ O\u2019Roak","year":"2014","unstructured":"O\u2019Roak, B. J. et al. Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nat. Commun. 5(1), 5595 (2014).","journal-title":"Nat. Commun."},{"issue":"1","key":"59907_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41525-019-0093-8","volume":"4","author":"P Feliciano","year":"2019","unstructured":"Feliciano, P. et al. Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes. NPJ Genom Med. 4(1), 19 (2019).","journal-title":"NPJ Genom Med."},{"issue":"4","key":"59907_CR54","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/dneu.22417","volume":"77","author":"V Martinez-Cerdeno","year":"2017","unstructured":"Martinez-Cerdeno, V. Dendrite and spine modifications in autism and related neurodevelopmental disorders in patients and animal models. Dev. Neurobiol. 77(4), 393\u2013404 (2017).","journal-title":"Dev. Neurobiol."},{"key":"59907_CR55","doi-asserted-by":"publisher","first-page":"781327","DOI":"10.3389\/fcell.2021.781327","volume":"9","author":"H Zhao","year":"2021","unstructured":"Zhao, H. et al. GABAergic System Dysfunction in Autism Spectrum Disorders. Front. Cell. Dev. Biol. 9, 781327 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"1","key":"59907_CR56","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/gbb.12257","volume":"15","author":"G Bissonette","year":"2016","unstructured":"Bissonette, G. & Roesch, M. Development and function of the midbrain dopamine system: what we know and what we need to. Genes Brain Behav. 15(1), 62\u201373 (2016).","journal-title":"Genes Brain Behav."},{"key":"59907_CR57","doi-asserted-by":"publisher","first-page":"1452526","DOI":"10.3389\/fphar.2024.1452526","volume":"15","author":"S Lee","year":"2024","unstructured":"Lee, S. et al. Population pharmacokinetic and pharmacodynamic model guided weight-tiered dose of AST-001 in pediatric patients with autism spectrum disorder. Front. Pharmacol. 15, 1452526 (2024).","journal-title":"Front. Pharmacol."},{"key":"59907_CR58","doi-asserted-by":"publisher","first-page":"1783915","DOI":"10.3389\/fpsyt.2026.1783915","volume":"17","author":"JI Kim","year":"2026","unstructured":"Kim, J. I. et al. Safety and Efficacy of AST-001 in Children with Autism Spectrum Disorder: A 52-week Multicenter Long-term Follow-up Study. Front. Psychiatry. 17, 1783915 (2026).","journal-title":"Front. Psychiatry"},{"issue":"3","key":"59907_CR59","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/cne.20230","volume":"476","author":"H Zhaoliang","year":"2004","unstructured":"Zhaoliang, H. et al. Differentiation of the midbrain dopaminergic pathways during mouse development. J. Comp. Neurol. 476(3), 301\u2013311 (2004).","journal-title":"J. Comp. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59907-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59907-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59907-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:02:31Z","timestamp":1791162151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59907-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59907"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59907-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were conducted at Astrogen Inc. in compliance with the relevant guidelines. Ethical approval was obtained from the Institutional Animal Care and Use Committee (IACUC) of the institution (Approval number: ASTA2023-004-V2).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30804"}}